Similarly, the T-cell expressed ICI target CTLA-4 has been imaged in preclinical mouse models of colon cancer to better understand target expression and therapy side effects (Higashikawa et al., 2014). This evidence concerns the gene CTLA4 and malignant colon neoplasm.